Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 3.3 | 8.7 | 22.8 | 0.1 | 0.2 | 41.5 | 19.3 |
| Revenue growth | -100.0% | -61.9% | -61.9% | 17555.0% | -25.9% | -99.6% | 115.2% | |
| Cost of goods sold | -3.9 | -29.0 | -0.1 | -0.1 | -67.0 | -63.3 | 0.0 | 0.0 |
| Gross profit | 3.9 | 32.3 | 8.8 | 22.9 | 67.2 | 63.4 | 41.5 | 19.3 |
| Gross margin | | 978.5% | 101.1% | 100.6% | 52070.5% | 36459.8% | 100.0% | 100.0% |
| Research and development | 12.7 | 20.4 | 27.9 | 40.6 | 28.1 | 25.8 | 17.0 | 7.2 |
| General and administrative | 7.4 | 8.5 | 11.1 | 8.3 | 5.5 | 6.0 | 3.7 | 2.5 |
| EBIT | -16.2 | 3.0 | -30.2 | -26.0 | 33.5 | 31.6 | 20.8 | 9.6 |
| EBIT margin | | 89.7% | -348.6% | -113.9% | 25985.3% | 18179.9% | 50.0% | 50.0% |
| Pre-tax income | -14.9 | 3.2 | -29.3 | -24.6 | 32.2 | 31.6 | 20.8 | 9.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -14.9 | 3.2 | -29.3 | -24.6 | 32.2 | 31.6 | 20.8 | 9.7 |
| Net margin | | 97.5% | -337.7% | -108.1% | 24963.6% | 18142.5% | 50.0% | 50.1% |
| |
| Diluted EPS | ($0.65) | $0.14 | ($1.30) | ($1.26) | $1.80 | $5.02 | $3.30 | $1.54 |
| Shares outstanding (diluted) | 23.1 | 23.6 | 22.6 | 19.5 | 17.9 | 6.3 | 6.3 | 6.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|